ANNALI AMD – Profili assistenziali nei soggetti con DM1 e DM2 in relazione al rischio cardiovascolare
Leggi
Risk of blindness among patients with diabetes and newly diagnosed diabetic retinopathy
Wykoff CC, Khurana RN, Nguyen QD, et al.
Diabetes Care. 2021 Jan;dc200413
Leggi
Effect of high-density lipoprotein cholesterol levels on overall survival and major adverse cardiovascular and cerebrovascular events
Kaur M, Ahuja KR, Khubber S, et al.
The American Journal of Cardiology. Pub. online 30 January 2021
Leggi
Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial
Mingrone G, Panunzi S, De Gaetano A, et al.
Lancet. 2021;397(10271):293-304
Leggi
Closed-loop insulin therapy improves glycemic control in adolescents and young adults: outcomes from the international diabetes closed-loop trial
Isganaitis E, Raghinaru D, Ambler-Osborn L, et al.
Diabetes Technol Ther. Pub online 21 January 2021
Leggi
The evolution of hemoglobin A1c targets for youth with type 1 diabetes: rationale and supporting evidence
Redondo MJ, Libman I, Maahs DM, et al.
Diabetes Care. 2021;44(2):301-312
Leggi
Effects of sotagliflozin combined with intensive insulin therapy in young adults with poorly controlled type 1 diabetes: The JDRF Sotagliflozin Study
Bode BW, Cengiz E, Wadwa RP, et al.
Diabetes Technol Ther. 2021;23(1):59-69.
Leggi
A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
Bergenstal RM, Nimri R, Beck RW, et al.
Lancet. 2021;397(10270):208-219.
Leggi
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
Palmer SC, Tendal B, Mustafa RA, et al.
BMJ 2021;372:m4573
Leggi